Reactions Weekly is the unique one-stop-shop for all your adverse drug reaction needs, bringing you up-to-the minute summaries of the world's adverse drug reaction news and comprehensive coverage of published adverse drug reaction case reports.
Reactions Weekly provides a weekly round-up of adverse drug reaction news including labelling changes, drug withdrawals due to safety issues, adverse reaction research and current issues in drug safety. Content is sourced from journals, scientific meetings, media releases, regulatory agency and pharmaceutical company websites, and bulletins from the more than 80 National Centers that participate in the WHO International Drug Monitoring Programme.
Reactions Weekly has comprehensive coverage of adverse drug reaction case reports published in the literature, through monitoring of all Medline- and Embase-indexed journals. All case summaries contain data as specified by the CIOMS II guidelines for International Reporting of Periodic Drug-Safety Update Summaries, providing you with the most pertinent information in an easy-to-read format.
Overdose, interaction, serious and first published case reports are highlighted; US FDA MedWatch criteria for classifying serious reactions are used and all first reports are verified by a search of the world's literature. Contextual adverse event data from the WHO Adverse Drug Reactions database are included for first reports.
Reactions Weekly is included in the following Collections: